Acuson delivers first Sequoia systems:
This article was originally published in Clinica
The first Acuson Sequoia ultrasound systems have been installed at two sites in the US and one in Japan. The system was introduced in April this year (see Clinica No 704, p 22).
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.